# Bristol-Myers Squibb (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/bristol-myers-squibb-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 39.6 |
| Citations | 4,601,003 |
| City | New York |
| Country | US |
| Description | Bristol-Myers Squibb (United States) is a research organisation in New York, US. OpenAlex records 22,768 works and 4,601,003 citations for it. 6,876 researchers list it as their most recent affiliation. |
| Homepage | https://www.bms.com/ |
| OpenAlex ID | https://openalex.org/I4210091812 |
| Region | New York |
| Researchers | 6,876 |
| ROR ID | https://ror.org/00gtmwv55 |
| Type | company |
| Works | 22,768 |

## University collaborators

Showing 10 of 13.

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)
- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)
- [Sidney Kimmel Comprehensive Cancer Center](https://scholariq.org/institutions/sidney-kimmel-comprehensive-cancer-center/)
- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)
- [Dana-Farber Cancer Institute](https://scholariq.org/institutions/dana-farber-cancer-institute/)
- [Moffitt Cancer Center](https://scholariq.org/institutions/moffitt-cancer-center/)
- [The Ohio State University](https://scholariq.org/institutions/the-ohio-state-university/)
- [Institut Gustave Roussy](https://scholariq.org/institutions/institut-gustave-roussy/)
- [Hadassah Medical Center](https://scholariq.org/institutions/hadassah-medical-center/)
- [Cancer Institute (WIA)](https://scholariq.org/institutions/cancer-institute-wia/)

## University papers

Showing 12 of 43.

- [Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer](https://scholariq.org/papers/safety-activity-and-immune-correlates-of-anti-pd-1-antibody-in-cancer/)
- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-squamous-cell-non-small-cell-lung-cancer/)
- [Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer](https://scholariq.org/papers/safety-and-activity-of-anti-pd-l1-antibody-in-patients-with-advanced-cancer/)
- [Functional profiling of the Saccharomyces cerevisiae genome](https://scholariq.org/papers/functional-profiling-of-the-saccharomyces-cerevisiae-genome/)
- [Functional Characterization of the <i>S. cerevisiae</i> Genome by Gene Deletion and Parallel Analysis](https://scholariq.org/papers/functional-characterization-of-the-i-s-cerevisiae-i-genome-by-gene-deletion-and/)
- [Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations](https://scholariq.org/papers/interpreting-the-clinical-importance-of-treatment-outcomes-in-chronic-pain/)
- [Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/idecabtagene-vicleucel-in-relapsed-and-refractory-multiple-myeloma/)
- [Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma](https://scholariq.org/papers/anti-bcma-car-t-cell-therapy-bb2121-in-relapsed-or-refractory-multiple-myeloma/)
- [Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial](https://scholariq.org/papers/activity-and-safety-of-nivolumab-an-anti-pd-1-immune-checkpoint-inhibitor-for/)
- [Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists](https://scholariq.org/papers/guidelines-for-performing-a-comprehensive-transesophageal-echocardiographic/)
- [Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure](https://scholariq.org/papers/carvedilol-produces-dose-related-improvements-in-left-ventricular-function-and/)

## University researchers

- [Timothy Campbell](https://scholariq.org/researchers/timothy-campbell/)
- [Yuanfang Xu](https://scholariq.org/researchers/yuanfang-xu/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [Chemical Synthesis and Analysis](https://scholariq.org/topics/chemical-synthesis-and-analysis/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Protein purification and stability](https://scholariq.org/topics/protein-purification-and-stability/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.